Skip to content
ProvidersDesk
Q0224

Inj, pemivibart, 4500 mg

✓ CURRENT — JULY 2026
Source: CMS
Imported: Aug 10 2026

Full descriptor

Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg

Details

Code
Q0224
Short descriptor
Inj, pemivibart, 4500 mg
Code set
HCPCS Level II
Release
July 2026
Status
Active
Added
Mar 22 2024

Nearby codes

Code sets are published in blocks, so neighbours are usually related.

Q0234

Inj, tocilizumab-bavi, 1mg

Q0235

Inj, monoclon antibody, 1 mg

Q0237

Inj, tocilizumab-anoh, hospi

Q0238

Inj, tocilizumab-aazg, hospi

Q0249

Tocilizumab for covid-19

Q0181

Unspecified oral anti-emetic

Q0180

Dolasetron mesylate oral

Q0177

Hydroxyzine pamoate 25mg

Sources

Reference information only. Not billing advice. Verify against the payer before you file.